Technical Analysis for KZR - Kezar Life Sciences, Inc.

Grade Last Price % Change Price Change
grade C 19.66 -3.58% -0.73
KZR closed down 3.58 percent on Monday, May 20, 2019, on 43 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical KZR trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Bollinger Band Squeeze Range Contraction -3.58%
200 DMA Resistance Bearish -4.52%
Shooting Star Candlestick Bearish -4.52%
Pocket Pivot Bullish Swing Setup -4.52%
Bollinger Band Squeeze Range Contraction -4.52%
BB Squeeze + Upper Band Touch Range Contraction -4.52%

Older signals for KZR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Biotechnology Cancer Life Sciences Pharmaceutical Companies
Is KZR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 14 Kezar Life Sciences Announces Presentations at Two Upcoming Investor Conferences
May 10 Here is What Hedge Funds Think About Kezar Life Sciences, Inc. (KZR)
May 7 Kezar Life Sciences beats by $0.03
May 7 Kezar Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
Apr 3 Kezar Life Sciences to Present at the 18th Annual Needham Healthcare Conference
Mar 28 Kezar Life Sciences Announces Presentations at Upcoming Scientific Conferences
Mar 26 Kezar Life Sciences beats by $0.15
Mar 26 Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
Mar 6 Kezar Life Sciences Announces Initiation of Clinical Study to Test a New Drug Product Formulation of KZR-616
Mar 5 Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
See more KZR news...
Indicators
Indicator Value
52 Week High 36.33
52 Week Low 14.77
Average Volume 95,290
200-Day Moving Average 20.8978
50-Day Moving Average 19.3458
20-Day Moving Average 19.891
10-Day Moving Average 20.155
Average True Range 1.1029
ADX 19.15
+DI 20.9665
-DI 15.7285
Chandelier Exit (Long, 3 ATRs ) 18.2913
Chandelier Exit (Short, 3 ATRs ) 21.4187
Upper Bollinger Band 21.0107
Lower Bollinger Band 18.7713
Percent B (%b) 0.4
BandWidth 11.258358
MACD Line 0.1732
MACD Signal Line 0.1767
MACD Histogram -0.0035
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.37
Resistance 3 (R3) 21.51 21.07 21.09
Resistance 2 (R2) 21.07 20.64 21.01 20.99
Resistance 1 (R1) 20.37 20.37 20.15 20.23 20.89
Pivot Point 19.93 19.93 19.83 19.87 19.93
Support 1 (S1) 19.23 19.50 19.01 19.09 18.43
Support 2 (S2) 18.79 19.23 18.73 18.33
Support 3 (S3) 18.09 18.79 18.24
Support 4 (S4) 17.95